Answers are grounded in this paper and cite their sources.
Aminoacyl-tRNA synthetases (ARSs) play an essential role in protein synthesis by matching amino acids to their corresponding tRNAs. While antibacterial ARS inhibitors are in clinical use and anti-plasmodial compounds are in development, relatively little work has been done to develop inhibitors of ARSs in multicellular parasites, including helminths. Although more than 150 helminth genomes have now been sequenced, sequence predictions for ARSs and other proteins are often not completely correct. Inaccuracies, usually due to incorrectly predicted intron-exon boundaries, hinder identification of novel drug targets and development of a more complete understanding of helminth biology. Using publicly available genomic information from a set of twelve human-infecting helminths, we identified and corrected gene model predictions for ARS sequences. We corrected exon boundary predictions using available RNA-seq data, then refined and validated these predictions by comparison to existing robust multiple-sequence alignments of ARS homologs from other eukaryotes, bacteria, and archaea, resulting in new models for more than 50% of the sequences. Although most helminth ARS sequences have high similarity to human homologs, we found several unique features of helminth aminoacyl-tRNA synthetases that may be exploited to develop novel anthelminthic therapies. These include unusual mitochondrially-targeted ARSs that lack known RNA-binding domains and cytosolic ARSs in which appended domains, known to mediate assembly of the multi-aminoacyl-tRNA synthetase complex in humans and other metazoans, are missing or replaced with unique, helminth-specific sequences.
No takes yet. Share an insight, caveat, or question.
Block et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: